Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2176 AL 2190

Protective effects of silk fibroin against 6-OHDA in SH-SY5Y human neuroblastoma cells and comparative study with its release from gelatin films

Ceccarini MR, Alunni Cardinali M, Malaspina R, Libera V, Scattini G, Codini M, Chiesa I, De Maria C, Comez L, Paciaroni A, Sassi P, Valentini L.

Int J Biol Macromol. 2025 Apr;303:140697. doi: 10.1016/j.ijbiomac.2025.140697. Epub 2025 Feb 4.

Balance exercise interventions in Parkinson's disease: A systematic mapping review of components, progression, and intensity

Wallin A, Franzén E, Studsgaard J, Hansen MB, Johansson S, Brincks JK.

Parkinsonism Relat Disord. 2025 Apr;133:107310. doi: 10.1016/j.parkreldis.2025.107310. Epub 2025 Jan 31.

Severe Colonic Dysmotility and Constipation Leading to Hydronephrosis in Advanced Parkinson's Disease: A Case Report and Literature Review

Isaac-Coss G, Kavuri S, Jayakumar J, Post Z, Sakuraba A.

Cureus. 2025 Jan 6;17(1):e77035. doi: 10.7759/cureus.77035. eCollection 2025 Jan.

An Unusual Presentation of Respiratory Dysfunction in Parkinson's Disease: A Case Study

Rundquist LD, Lyons SE, Moljo RJ, Blavo C.

Cureus. 2025 Jan 7;17(1):e77101. doi: 10.7759/cureus.77101. eCollection 2025 Jan.

[Urinary disturbances in parkinsonism]

Andersen MFB, Fode M, Seifert R, Winge K.

Ugeskr Laeger. 2025 Jan 13;187(3):V07240496. doi: 10.61409/V07240496.

Targeting Neurodegeneration: The Emerging Role of Hybrid Drugs

Deb D, Dhanawat M, Bhushan B, Pachuau L, Das N.

Curr Drug Targets. 2025;26(6):410-434. doi: 10.2174/0113894501365588250131073304.

Prevalence of Parkinson's Disease in 22q11.2 Deletion Syndrome: A Multicenter Study

von Scheibler ENMM, Swillen A, Repetto GM, Reyes NGD, Lang AE, Marras C, Kuijf ML, Rouhl RPW, van Eeghen AM, Juri C, Vogels A, van Amelsvoort TAMJ, Bassett AS, Boot E.

Mov Disord Clin Pract. 2025 Jun;12(6):817-822. doi: 10.1002/mdc3.14354. Epub 2025 Feb 7.

The basics of PET molecular imaging in neurodegenerative disorders with dementia and/or parkinsonism

Bronte A, Prieto E, Quincoces G, Erro E, Arbizu J.

Eur Radiol. 2025 Aug;35(8):4621-4634. doi: 10.1007/s00330-025-11388-5. Epub 2025 Feb 6.

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

Vijiaratnam N, Girges C, Auld G, McComish R, King A, Skene SS, Hibbert S, Wong A, Melander S, Gibson R, Matthews H, Dickson J, Carroll C, Patrick A, Inches J, Silverdale M, Blackledge B, Whiston J, Hu M, Welch J, Duncan G, Power K, Gallen S, Kerr J, Chaudhuri KR, Batzu L, Rota S, Jabbari E, Morris H, Limousin P, Greig N, Li Y, Libri V, Gandhi S, Athauda D, Chowdhury K, Foltynie T.

Lancet. 2025 Feb 22;405(10479):627-636. doi: 10.1016/S0140-6736(24)02808-3. Epub 2025 Feb 4.

Corrigendum to "Qiji Shujiang granules alleviates dopaminergic neuronal injury of parkinson's disease by inhibiting NLRP3/Caspase-1 pathway mediated pyroptosis" [Phytomedicine, 120, 2023, 155019]

Huan P, Sun X, He Z, Yang S, Wang X, Xie H, Wang L, He J.

Phytomedicine. 2025 Mar;138:156421. doi: 10.1016/j.phymed.2025.156421. Epub 2025 Feb 6.

Neuroimaging and cognitive correlates of postural control in Parkinson's disease: a systematic review

Tait P, Graham L, Vitorio R, Watermeyer T, Timm EC, O'Keefe J, Stuart S, Morris R.

J Neuroeng Rehabil. 2025 Feb 8;22(1):24. doi: 10.1186/s12984-024-01539-y.

Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer's disease and Parkinson's disease: Therapeutic avenue of Dual OXR Antagonist (DORA)

Panda SP, Sinha S, Kesharwani A, Kumar S, Singh M, Kondepudi GM, Samuel A, Sanghi AK, Thapliyal S, Chaubey KK, Guru A.

Biochem Pharmacol. 2025 Mar;233:116794. doi: 10.1016/j.bcp.2025.116794. Epub 2025 Feb 5.

A case-control comparison of pruritus and neurodegenerative disease: insights from comorbidities and demographic profiles

Kooner A, Dutt A, Sekhon RA.

Arch Dermatol Res. 2025 Feb 8;317(1):376. doi: 10.1007/s00403-025-03881-0.

Non-pharmacological rehabilitation for people living with advanced Parkinson's disease: A scoping review of interventions

Elbek JA, Nørgaard B, Pedersen T, Thuesen J.

Parkinsonism Relat Disord. 2025 Apr;133:107317. doi: 10.1016/j.parkreldis.2025.107317. Epub 2025 Feb 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias